Literature DB >> 14575363

Glycemic index and load and risk of upper aero-digestive tract neoplasms (Italy).

Livia S A Augustin1, Silvano Gallus, Silvia Franceschi, Eva Negri, David J A Jenkins, Cyril W C Kendall, Luigino Dal Maso, Renato Talamini, Carlo La Vecchia.   

Abstract

BACKGROUND: The ability of dietary carbohydrates to affect blood glucose and insulin levels by dietary carbohydrates is best measured by the glycemic index (GI) and glycemic load (GL) which have been directly associated with risk of several chronic conditions, including cancer. PATIENTS AND METHODS: Three case-control studies were conducted between 1992 and 2000 in Italy. The first one included 598 hospital patients with incident, histologically confirmed oral and pharyngeal cancer and 1491 controls admitted to the same hospital networks for acute, non-neoplastic diseases; the second study included 304 subjects with squamous cell oesophageal cancer and 743 controls; the third one included 460 cases with laryngeal cancer and 1088 controls. All subjects were interviewed using a validated food frequency questionnaire.
RESULTS: The odds ratios (OR) of upper aero-digestive tract neoplasms for the highest versus the lowest quintile of dietary GI and GL were 1.5 (95% confidence interval [CI]: 1.1-2.0) and 1.8 (95% CI: 1.1-2.9), respectively. The associations were in the same direction for various cancer sites. The ORs were apparently stronger in women, in those with high body mass index and reporting low alcohol consumption.
CONCLUSIONS: This study supports the hypothesis that high dietary GI and GL are associated with cancers of the upper aero-digestive tract.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575363     DOI: 10.1023/a:1025676907942

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  9 in total

1.  Nutrition and cancer: a review of the evidence for an anti-cancer diet.

Authors:  Michael S Donaldson
Journal:  Nutr J       Date:  2004-10-20       Impact factor: 3.271

2.  Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.

Authors:  Grace Sun; Sangeeta R Kashyap
Journal:  J Nutr Metab       Date:  2011-06-01

3.  Relationship between plasma glucose levels and malignant uterine cervical neoplasias.

Authors:  Rosekeila Simões Nomelini; Adriano Souza Lima Neto; Kalebe Alexandre Capuci; Beatriz Martins Tavares Murta; Eddie Fernando Candido Murta
Journal:  Clin Med Insights Oncol       Date:  2011-04-06

Review 4.  Perceived barriers to application of glycaemic index: valid concerns or lost in translation?

Authors:  Shannan M Grant; Thomas M S Wolever
Journal:  Nutrients       Date:  2011-02-28       Impact factor: 6.706

5.  A case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer Study.

Authors:  Petra H Lahmann; Torukiri I Ibiebele; Penelope M Webb; Christina M Nagle; David C Whiteman
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430

6.  Dietary inflammatory index and risk of upper aerodigestive tract cancer in Japanese adults.

Authors:  Makiko Abe; Nitin Shivappa; Hidemi Ito; Isao Oze; Tetsuya Abe; Yasuhiro Shimizu; Yasuhisa Hasegawa; Chikako Kiyohara; Masatoshi Nomura; Yoshihiro Ogawa; James R Hebert; Keitaro Matsuo
Journal:  Oncotarget       Date:  2018-05-08

7.  Dietary glycemic load and gastric cancer risk in Italy.

Authors:  P Bertuccio; D Praud; L Chatenoud; E Lucenteforte; C Bosetti; C Pelucchi; M Rossi; E Negri; C La Vecchia
Journal:  Br J Cancer       Date:  2009-02-10       Impact factor: 7.640

Review 8.  Aetiology of oral cancer in the Sudan.

Authors:  Hussain Gadelkarim Ahmed
Journal:  J Oral Maxillofac Res       Date:  2013-07-01

9.  Foods, nutrients and the risk of oral and pharyngeal cancer.

Authors:  F Bravi; C Bosetti; M Filomeno; F Levi; W Garavello; S Galimberti; E Negri; C La Vecchia
Journal:  Br J Cancer       Date:  2013-10-22       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.